Abstract
Mesoporous nanoparticles have emerged as a promising vehicle for targeted drug delivery in cancer therapy, offering a combination of high surface area, tunable pore sizes, and biocompatibility. These nanostructured materials facilitate the encapsulation and controlled release of therapeutic agents, enhancing drug solubility, stability, and bioavailability. Leveraging surface functionalization, mesoporous nanoparticles can be engineered to recognize and bind to specific cancer cell receptors, ensuring precise delivery of anticancer drugs while minimizing systemic toxicity. This abstract explores the synthesis, functionalization, and therapeutic efficacy of mesoporous nanoparticles in cancer treatment, highlighting their potential to revolutionize current oncological practices by improving the specificity and efficiency of drug delivery systems.